Development of a semi-quantitative risk assessment model for evaluating environmental threat posed by the three first EU watch-list pharmaceuticals to urban wastewater treatment plants: An Irish case study

Barbosa, 2016, Occurrence and removal of organic micropollutants: an overview of the watch list of EU decision 2015/495, Water Res., 94, 257, 10.1016/j.watres.2016.02.047

Bastola, 2011, The sensitivity of fluvial flood risk in Irish catchments to the range of IPCC AR4 climate change scenarios, Sci. Total Environ., 409, 5403, 10.1016/j.scitotenv.2011.08.042

Ben Fredj, 2015, Removal of estrone (E1), 17β-estradiol (E2), and 17α-ethinylestradiol (EE2) from wastewater by liquid–liquid extraction, Chem. Eng. J., 262, 417, 10.1016/j.cej.2014.10.007

Boxall, 2010, Veterinary medicines and the environment, 291

Boxall, 2014, Exploiting monitoring data in environmental exposure modelling and risk assessment of pharmaceuticals, Environ. Int., 73, 176, 10.1016/j.envint.2014.07.018

Buchberger, 2011, Current approaches to trace analysis of pharmaceuticals and personal care products in the environment, J. Chromatogr. A, 1218, 603, 10.1016/j.chroma.2010.10.040

Burkhardt-Holm, 2010, Endocrine disruptors and water quality: a state-of-the-art review, Int. J. Water Qual., 16, 477

Cirja, 2008, Factors affecting the removal of organic micropollutants from wastewater in conventional treatment plants (CTP) and membrane bioreactors (MBR), Rev. Environ. Sci. Biotechnol., 7, 61, 10.1007/s11157-007-9121-8

Clara, 2005, Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants, Water Res., 39, 4797, 10.1016/j.watres.2005.09.015

EPA, 2010, Environmental Protection Agency, 1

EPA, 2015, 1

European Medicines Agency, 2014

Fent, 2006, Ecotoxicology of human pharmaceuticals, Aquat. Toxicol., 76, 122, 10.1016/j.aquatox.2005.09.009

Gill, 2009, Natural attenuation of endocrine disrupting chemicals in on-site domestic wastewater treatment systems, J. ASTM Int., 6, 1, 10.1520/JAI102170

Ginebreda, 2010, Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain), Environ. Int., 36, 153, 10.1016/j.envint.2009.10.003

de Graaff, 2011, Fate of hormones and pharmaceuticals during combined anaerobic treatment and nitrogen removal by partial nitritation-anammox in vacuum collected black water, Water Res., 45, 375, 10.1016/j.watres.2010.08.023

Gros, 2010, Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes, Environ. Int., 36, 15, 10.1016/j.envint.2009.09.002

Guillén, 2012, Prioritization of chemicals in the aquatic environment based on risk assessment: analytical, modeling and regulatory perspective, Sci. Total Environ., 440, 236, 10.1016/j.scitotenv.2012.06.064

Hecker, 2011, Endocrine disruptor screening: regulatory perspectives and needs, Environ. Sci. Eur., 23, 1, 10.1186/2190-4715-23-15

Hernando, 2006, Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments, Talanta, 69, 334, 10.1016/j.talanta.2005.09.037

Joss, 2006, Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme, Water Res., 40, 1686, 10.1016/j.watres.2006.02.014

Kosma, 2014, Investigation of PPCPs in wastewater treatment plants in Greece: occurrence, removal and environmental risk assessment, Sci. Total Environ., 466–467, 421, 10.1016/j.scitotenv.2013.07.044

Kümmerer, 2009, The presence of pharmaceuticals in the environment due to human use – present knowledge and future challenges, J. Environ. Manag., 90, 2354, 10.1016/j.jenvman.2009.01.023

Kümmerer, 2009, The presence of pharmaceuticals in the environment due to human use – present knowledge and future challenges, J. Environ. Manag., 90, 2354, 10.1016/j.jenvman.2009.01.023

Kunz, 2015, In vitro bioassays to screen for endocrine active pharmaceuticals in surface and waste waters, J. Pharm. Biomed. Anal., 106, 107, 10.1016/j.jpba.2014.11.018

ter Laak, 2010, Relating environmental concentrations of pharmaceuticals to consumption: a mass balance approach for the river Rhine, Environ. Int., 36, 403, 10.1016/j.envint.2010.02.009

Lacey, 2008, An LC–MS method for the determination of pharmaceutical compounds in wastewater treatment plant influent and effluent samples, Talanta, 75, 1089, 10.1016/j.talanta.2008.01.011

Lacey, 2012, Occurrence of pharmaceutical compounds in wastewater process streams in Dublin, Ireland, Environ. Monit. Assess., 184, 1049, 10.1007/s10661-011-2020-z

Lapworth, 2012, Emerging organic contaminants in groundwater: a review of sources, fate and occurrence, Environ. Pollut., 163, 287, 10.1016/j.envpol.2011.12.034

Lienert, 2007, Reducing micropollutants with source control: substance flow analysis of 212 pharmaceuticals in faeces and urine, Water Sci. Technol., 56, 87, 10.2166/wst.2007.560

Lindim, 2017, Model-predicted occurrence of multiple pharmaceuticals in Swedish surface waters and their flushing to the Baltic Sea, Environ. Pollut., 223, 595, 10.1016/j.envpol.2017.01.062

Miege, 2008, Removal efficiency of pharmaceuticals and personal care products with varying wastewater treatment processes and operating conditions – conception of a database and first results, Water Sci. Technol., 57, 49, 10.2166/wst.2008.823

Nikolaou, 2007, Occurence patterns of pharmaceuticals in water and wastewater environments, Anal. Bioanal. Chem., 387, 1225, 10.1007/s00216-006-1035-8

Oaks, 2004, Diclofenac residues as the cause of vulture population decline in Pakistan, Nature, 427, 630, 10.1038/nature02317

Pereira, 2015, Environmental impact of pharmaceuticals from Portuguese wastewaters: geographical and seasonal occurrence, removal and risk assessment, Environ. Res., 136, 108, 10.1016/j.envres.2014.09.041

Petrie, 2013, Fate of drugs during wastewater treatment, TrAC Trends Anal. Chem., 49, 145, 10.1016/j.trac.2013.05.007

Qian, 2015, A bibliometric analysis of global research progress on pharmaceutical wastewater treatment during 1994–2013, Environ. Earth Sci., 73, 4995, 10.1007/s12665-015-4183-3

Quinn-Hosey, 2012, A toxicological assessment of endocrine disrupting chemicals found in BMW (border, midland and western) region of Ireland, J. Environ. Prot., 3, 304, 10.4236/jep.2012.34039

Rivera-Utrilla, 2013, Pharmaceuticals as emerging contaminants and their removal from water. A review, Chemosphere, 93, 1268, 10.1016/j.chemosphere.2013.07.059

Ronan, 2013, A sensitive liquid chromatography/tandem mass spectrometry method for the determination of natural and synthetic steroid estrogens in seawater and marine biota, with a focus on proposed water framework directive environmental quality standards, Rapid Commun. Mass Spectrom., 27, 738, 10.1002/rcm.6505

Santos, 2010, Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment, J. Hazard. Mater., 175, 45, 10.1016/j.jhazmat.2009.10.100

Simon, 2015, Challenges in effect-directed analysis with a focus on biological samples, TrAC Trends Anal. Chem., 67, 179, 10.1016/j.trac.2015.01.006

Streck, 2009, Chemical and biological analysis of estrogenic, progestagenic and androgenic steroids in the environment, TrAC Trends Anal. Chem., 28, 635, 10.1016/j.trac.2009.03.006

Tarrant, 2005, 1

Thomas, 2007, Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works, J. Environ. Monit., 9, 1410, 10.1039/b709745j

Tiedeken, 2016, Investigation of the implications for Ireland of emerging standards on pharmaceuticals in receiving waters, EPA Research Report

Tiedeken, 2017, Monitoring, sources, receptors, and control measures for three European Union watch list substances of emerging concern in receiving waters – a 20 year systematic review, Sci. Total Environ., 574, 1140, 10.1016/j.scitotenv.2016.09.084

UWWTD-REP Working Group, 2006

Verlicchi, 2016, Predicted and measured concentrations of pharmaceuticals in hospital effluents. Examination of the strengths and weaknesses of the two approaches through the analysis of a case study, Sci. Total Environ., 565, 82, 10.1016/j.scitotenv.2016.04.165

Verlicchi, 2012, Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment—a review, Sci. Total Environ., 429, 123, 10.1016/j.scitotenv.2012.04.028

Verlicchi, 2012, Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment—a review, Sci. Total Environ., 429, 123, 10.1016/j.scitotenv.2012.04.028

Vieno, 2014, Fate of diclofenac in municipal wastewater treatment plant — a review, Environ. Int., 69, 28, 10.1016/j.envint.2014.03.021

Wille, 2012, Coupled chromatographic and mass-spectrometric techniques for the analysis of emerging pollutants in the aquatic environment, TrAC Trends Anal. Chem., 35, 87, 10.1016/j.trac.2011.12.003

Wise, 2011, Are oral contraceptives a significant contributor to the estrogenicity of drinking water?, Environ. Sci. Technol., 45, 51, 10.1021/es1014482

Zhang, 2008, Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies, Chemosphere, 73, 1151, 10.1016/j.chemosphere.2008.07.086

Ziylan, 2011, The occurrence and fate of anti-inflammatory and analgesic pharmaceuticals in sewage and fresh water: treatability by conventional and non-conventional processes, J. Hazard. Mater., 187, 24, 10.1016/j.jhazmat.2011.01.057